Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells

Anesthesiology

Volumn 92, Issue 4, 2000, Pages 1074-1081

  Veien, Mette ^b   Szlam, Fania ^b   Holden, Jeannine T ^b   Yamaguchi, Koji ^b   Denson, Donald D ^b   Levy, Jerrold H ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Anaphylaxis; Mediator release; Phospholipases

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ATRACURIUM; ATRACURIUM BESILATE; CALCIMYCIN; HISTAMINE; MORPHINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE C; TRYPTASE; VANCOMYCIN;

ANAPHYLAXIS; ARTICLE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; NEWBORN; PRIORITY JOURNAL;

EID: 0034033880     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200004000-00026     Document Type: Article

References (41)

1. Caulfield JP, El-Lati S, Thomas G, Church MK: Dissociated human foreskin mast cells degranulate in response to anti-IgE and substance P. Lab Invest 1990; 63:502-10
2. Tharp MD, Suvunrugsi RT, Sullivan TJ: IgE-mediated release of histamine from human cutaneous mast cells. J Immunol 1983; 130: 1896-901
3. Levy JH, Kettlekamp N, Goertz P, Hermens J, Hirshman CA: Histamine release by vancomycin: A mechanism for hypotension in man. ANESTHESIOLOGY 1987; 67:122-5
4. Benyon CR, Church MK, Clegg SL, Holgate ST: Dispersion and characterisation of mast cells from human skin. Int Arch Allergy Appl Immunol 1986; 79:332-4
5. Stellato C, Cirillo R, Paulis AD, Casolaro V, Patella V, Mastronardi P, Mazzarella B, Marone G: Human basophil/mast cell releasability: IX. Heterogeneity of the effects of opioids on mediator release. ANESTHESIOLOGY 1992; 77:932-40
6. North FC, Kettelkamp N, Hirshman CA: Comparison of cutaneous and in vitro histamine release by relaxants. ANESTHESIOLOGY 1987; 66: 543-6
7. Stellato C, Paulis AD, Cirillo R, Mastronardi P, Mazzarella P, Marone G: Heterogeneity of human mast cells and basophils in response to muscle relaxants. ANESTHESIOLOGY 1991; 74:1078-86
8. Hogan AD, Schwartz LB: Markers of mast cell degranulation. Methods 1997; 13:43-52
9. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T: Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316:1622-6
10. Benyon CR, Robinson C, Church MK: Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Phamacol 1989; 97:898-904
11. 2. Crit Rev Immunol 1997; 17:225-83
12. Hirshman CA, Edelstein RA, Ebertz MJ, Hanifin JM: Thiobarbiturate-induced histamine release in human skin mast cells. ANESTHESIOLOGY 1985; 63:353-6
13. Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM: Purification and characterization of human skin mast cells. Evidence for human mast cell hetrogeneity. J Immunol 1987; 139:3062-9
14. Sauder RA, Hirshman CA: Protamine-induced histamine release in human skin mast cells. ANESTHESIOLOGY 1990; 73:165-7
15. Paulis AD, Stellato C, Cirillo R, Ciccarelli A, Oriente A, Marone G: Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol 1992; 99:723-8
16. Okayama Y, El-Lati SG, Leiferman KM, Church MK: Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. J Allergy Clin Immunol 1994; 93:900-9
17. Levy JH, Adelson A, Walker B: Wheal and flare responses to muscle relaxants in humans. Agents Actions 1991; 34:302-8
18. Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R, Moss J: Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. ANESTHESIOLOGY 1998; 89:620-5
19. Pressman BC: Biological applications of ionophores. Annu Rev Biochem 1976; 45:501-30
20. Takamori M, Yoshihiko Y, Mitsuhiro T: Pharmacophysiological study on muscle treated with calcium ionophore A23187. J Neurol Sci 1981; 50:89-94
21. Church MK, Pao GJK, Holgate ST: Characterization of histamine secretion from mechanically dispersed human lung mast cells: Effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol 1982; 129:2116-21
22. Weidner N, Austen FK: Evidence for morphologic diversity of human mast cells: An ultrastructural study of mast cells from multiple body sites. Lab Invest 1990; 63:63-71
23. Benyon CR, Lowman MA, Church MK: Human skin mast cells: Their dispersion, purification, and secretory characterization. J Immunol 1987; 138:861-7
24. Naguib M, Samarkandi AH, Bakhamees HS, Magboul MA, El-Bakry AK: Histamine release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth 1995; 75:588-92
25. Doenicke A, Moss J, Lorenz W, Hoernecke R, Gottardis M: Are hypotension and rash after atracurium really caused by histamine release? Anesth Analg 1994; 78:967-72
26. Patella V, Marinò I, Lampärter B, Arbustini E, Adt M, Marone G: Human heart mast cells: Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995; 154:2855-65
27. Paulis AD, Marinò I, Ciccarelli A, Crescenzo GD, Concardi M, Verga L, Arbustini E, Marone G: Human synovial mast cells: Ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum 1996; 39:1222-33
28. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D: Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989; 83:1551-5
29. Laroche D, Vergnaud MC, Sillard B, Soufarapis H, Bricard H: Biochemical markers of anaphylactoid reactions to drugs. ANESTHESIOLOGY 1991; 75:945-9
30. Watkins J: Adverse reaction to neuromuscular blockers: Frequency, investigation, and epidemiology. Acta Anaesthesiol Scand 1994; 38(suppl 102):6-10
31. Fisher MM, Baldo BA: Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998; 80:26-9
32. Edston E, van Hage-Hamsten M: Anapylactic shock: A common cause of death in heroin addicts? Allergy 1997; 52:959-4
33. Levy JH: Nonimmunologic (Pharmacologic) Histamine Release, Anaphylactic Reactions in Anesthesia and Intensive Care, 2nd edition. Stoneham, Butterworth-Heinemann, 1992, pp 63-80
34. Lowman MA, Benyon CR, Church MK: Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br J Pharmacol 1988; 95:121-30
35. Erbertz JM, Hermens JM, McMillan JC, Uno H, Hirshman CA, Hanifin JM: Functional differences between human cutaneous mast cells and basophils: A comparison of morphine-induced histamine release. Agents Action 1986; 18:455-62
36. Stellato C, Paulis AD, Cicarelli A, Cirillo R, Patella V, Casolaro V, Marone G: Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 1992; 98:800-4
37. El-Lati SG, Dahinden CA, Church MK: Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 1994; 102:803-6
38. 2 from activated mast cells and its possible involvement in the regulation of the degranulation process. Eur J Biochem 1992; 209:257-65
39. 2. J Immunol 1993; 151:5675-84
40. Laroche D, Gastin-Aimone I, Dubois F, Huet H, Gerard P, Vergnaud MC, Mouton-Faivre C, Gueant JL, Laxenaire MC, Bricard H: Mechanism of severe, immediate reactions to iodinated contrast material. Radiology 1998; 209:183-90
41. Schwartz LB: Mediators of human mast cells and human mast cell subsets. Ann Allergy 1987; 58:226-37